Effect of fluvastatin on apoptosis in human CD4+ T cells

Cellular Immunology

Volumn 235, Issue 2, 2005, Pages 136-144

  Samson, Karen Thursday R ^a,b   Minoguchi, Kenji ^a   Tanaka, Akihiko ^a   Oda, Naruhito ^a   Yokoe, Takuya ^a   Okada, Shinji ^a   Yamamoto, Yoshitaka ^a   Watanabe, Yoshio ^a   Yamamoto, Mayumi ^a   Ohta, Shin ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY   (Japan)

^b Cardinal Santos Medical Center   (Philippines)

Author keywords

Apoptosis; Cell proliferation; Statin; T cells

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CD4 ANTIGEN; CYTOCHROME C; FLUINDOSTATIN; IONOMYCIN; LIPOCORTIN 5; PHORBOL 13 ACETATE 12 MYRISTATE; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIZATION; STAINING; T LYMPHOCYTE;

ANTIBODIES; ANTIGENS, CD3; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOCHROMES C; DOWN-REGULATION; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDOLES; IONOMYCIN; LYMPHOCYTE ACTIVATION; PHORBOL 12,13-DIBUTYRATE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 27744499910     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.08.028     Document Type: Article

References (38)

1. A.L. Bishop, and A. Hall Rho GTPases and their effector proteins Biochem. J. 348 2000 241 255
2. A. Corsini Fluvastatin: effects beyond cholesterol lowering J. Cardiovasc. Pharmacol. Therapeut. 5 2000 161 175
3. U. Schonbeck, and P. Libby Inflammation, immunity, and HMG-CoA reductase inhibitors. Statins as anti-inflammatory agents? Circulation 109 Suppl. II 2004 II18 II26
4. D.Z. Hillyard, A.J. Cameron, A.H. McIntyre, M.H. Hadden, H.E. Marshall, N. Johnston, and A.G. Jardine Inhibition of proliferation and signaling mechanisms in human lymphocytes by fluvastatin Clin. Exp. Pharmacol. Physiol. 29 2002 673 678
5. G. Weitz-Schmidt, K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat. Med. 7 2001 687 692
6. B. Kwak, F. Mulhaupt, S. Myit, and F. Mach Statins as a newly recognized type of immunomodulator Nat. Med. 6 2000 1399 1402
7. F.J. Murphy, I. Hayes, and T.G. Cotter Targeting inflammatory diseases via apoptotic mechanisms Curr. Opin. Pharmacol. 3 2003 412 419
8. S. Kaneta, K. Satoh, S. Kano, M. Kanda, and K. Ichihara All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells Atherosclerosis 170 2003 237 243
9. X. Li, L. Liu, J.C. Tupper, D.D. Bannerman, R.K. Winn, S.M. Sebti, A.D. Hamilton, and J.M. Harlan Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells J. Biol. Chem. 277 2002 15309 15316
10. L.M. Blanco-Colio, A. Villa, M. Ortego, M.A. Hernandez-Presa, A. Pascual, J.J. Plaza, and J. Egido 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atrovastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho prenylation Atherosclerosis 161 2002 17 26
11. C. Guijarro, L.M. Blanco-Colio, M. Ortego, C. Alonso, A. Ortiz, J.J. Plaza, C. Diaz, G. Hernandez, and J. Egido 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture Circ. Res. 83 1998 490 500
12. B.P. Leung, N. Sattar, A. Crilly, M. Prach, D.W. McCarey, H. Payne, R. Madhok, C. Campbell, J.A. Gracie, F.Y. Liew, and I.B. McInnes A novel anti-inflammatory role for simvastatin in inflammatory arthritis J. Immunol. 170 2003 1524 1530
13. A. McKay, B.P. Leung, I.B. McInnes, N.C. Thomson, and F.Y. Liew A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma J. Immunol. 172 2004 2903 2908
14. T. Fehr, C. Kahlert, W. Fierz, H.I. Joller-Jemelka, W.F. Riesen, H. Rickli, R.P. Wuthrich, and P. Ammann Statin-induced immunomodulatory effects on human T cells in vivo Atherosclerosis 175 2004 83 90
15. N. Oda, K. Minoguchi, T. Yokoe, T. Hashimoto, K. Wada, M. Miyamoto, A. Tanaka, Y. Kohno, and M. Adachi Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines Life Sci. 65 1999 763 770
16. J.P. Aubry, A. Blaecke, S. Lecoanet-Henchoz, P. Jeannin, N. Herbault, G. Caron, V. Moine, and J.Y. Bonnefoy Annexin V used for measuring apoptosis in the early events of cellular toxicity Cytometry 37 1999 197 204
17. O. Janssen, A. Stocker, R. Sanzenbacher, H.H. Oberg, M.A. Siddiqi, and D. Kabelitz Differential regulation of activation-induced cell death in individual human T cell clones Int. Arch. Allergy Immnol. 121 2000 183 193
18. A. Rezaie-Majd, G.W. Prager, R.A. Bucek, G.H. Schernthaner, T. Maca, H.G. Kress, P. Valent, B.R. Binder, E. Minar, and M. Baghestanian Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients Arterioscler. Thromb. Vasc. Biol. 23 2003 397 403
19. Y. Kureishi, Z. Luo, I. Shiojima, A. Bialik, D. Fulton, D.J. Lefer, W.C. Sessa, and K. Walsh The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat. Med. 6 2000 1004 1010
20. B.A. Johnson, A.T. Iacono, A. Zeevi, K.R. McCurry, and S.R. Duncan Statin use is associated with improved function and survival of lung allografts Am. J. Respir. Crit. Care Med. 167 2003 1271 1278
21. J.A. Kobashigawa, S. Katznelson, H. Laks, J.A. Johnson, L. Yeatman, X.M. Wang, D. Chia, P.I. Terasaki, A. Sabad, G.A. Cogert, K. Trosian, M.A. Hamilton, J.D. Moriguchi, N. Kawata, A. Hage, D.C. Drinkwater, and L.W. Stevenson Effect of pravastatin on outcomes after cardiac transplantation N. Engl. J. Med. 333 1995 621 627
22. H. Holdaas, A.G. Jardine, D.C. Wheeler, I.B. Brekke, P.J. Conlon, B. Fellstrom, A. Hammad, I. Holme, H. Isoniemi, R. Moore, P.A. Rowe, P. Sweny, D.A. Talbot, J. Wadstrom, and O. Ostraat Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial Kidney Int. 60 2001 1990 1997
23. C.A. Guimaraes, and R. Linden Programmed cell death: apoptosis and alternative deathstyles Eur. J. Biochem. 271 2004 1638 1650
24. R.C. Budd Activation-induced cell death Curr. Opin. Immunol. 13 2001 356 362
25. D.R. Green Overview: apoptotic signaling pathways in immune system Immunol. Rev. 193 2003 5 9
26. T. Kubota, K. Fujisaki, Y. Itoh, T. Yano, T. Sendo, and R. Oishi Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors Biochem. Pharmacol. 67 2004 2175 2186
27. K. Newton, and A. Strasser Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system Genes Dev. 17 2003 819 825
28. A.C. Knapp, J. Huang, G. Starling, and P.A. Kiener Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death Atherosclerosis 152 2000 217 227
29. L.M. Blanco-Colio, B. Munoz-Garcia, L. Martin-Ventura, C. Lorz, C. Diaz, G. Hernandez, and J. Egido 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes Circulation 108 2003 1506 1513
30. T. Sato, T. Machida, S. Takahashi, S. Iyama, Y. Sato, K. Kuribayashi, K. Takada, T. Oku, Y. Kawano, T. Okamoto, R. Takimoto, T. Matsunaga, T. Takayama, M. Takahashi, J. Kato, and Y. Niitsu Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells J. Immunol. 173 2004 285 296
31. H.Y. Chang, and X. Yang Proteases for cell suicide: Functions and regulations of caspases Microbiol. Mol. Biol. Rev. 64 2000 821 846
32. X.M. Yin Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways Cell Res. 10 2000 161 167
33. M. Donovan, and T.G. Cotter Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death Biochim. Biophys. Acta 1644 2004 133 147
34. V.S. Marsden, L. O'Connor, L.A. O'Reilly, J. Silke, D. Metcalf, P.G. Ekert, D.C.S. Huang, F. Cecconi, K. Kuida, K.J. Tomaselli, S. Roy, D.W. Nicholson, D.L. Vaux, P. Bouillet, J.M. Adams, and A. Strasser Apoptosis initiated by Bcl-2-regulated caspases activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome Nature 419 2002 634 637
35. E.M. Creagh, H. Conroy, and S.J. Martin Caspase-activation pathways in apoptosis and immunity Immunol. Rev. 193 2003 10 21
36. A.H. Wagner, M. Gebauer, B. Guldenzoph, and M. Hecker 3-Hydroxy-3-methylglutaryl-CoA reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells Arterioscler. Thromb. Vasc. Biol. 22 2002 1784 1789
37. J. Gomez, C. Martinez, M. Giry, A. Garcia, and A. Rebolla Rho prevents apoptosis through Bcl-2 expression: implications for interleukin-2 receptor signal transduction Eur. J. Immunol. 27 1997 2793 2799
38. N. Masuda, I. Akasaka, J. Suzuki, A. Fujino, M. Ohtawa, N. Nakaya, Y. Goto, N. Takahashi, H. Sekino, T. Amamoto, A. Urae, A. Maeda, and S. Irie Phase I study of fluvastatin, a new synthetic HMG-CoA reductase inhibitor.- Pharmacokinetics of fluvastatin in healthy male volunteers after single and multiple oral administrations Rinshouiyaku 11 Suppl. 1 1995 65 81